Archive — US — techcrunch
Eyebot gets $20M Series A to boost to expand eye care access
Eyebot, a Boston-based startup offering quick vision tests via kiosks, has secured $20M in Series A funding to enhance access to eye care. Founded in 2021, it aims to overcome traditional barriers to vision care by providing doctor-verified prescriptions. With over 45,000 tests conducted, the funding will support scaling operations and kiosk deployment nationwide.
Key points
- Eyebot secures $20M in Series A funding, bringing total to over $30M.
- Founded in 2021, Eyebot offers a 90-second vision test that results in a prescription reviewed by licensed eye doctors.
- Kiosks are placed in various high-traffic locations, enhancing accessibility.
- The startup has conducted over 45,000 tests and plans to exceed 500,000 annually.
- Funding will be used to expand kiosk deployment and increase team size.
Why it matters
- The trend of deploying health tech solutions aligns with the push for increased access to healthcare services, particularly in eye care.
- Similar companies in the telehealth space have gained traction, indicating a shift towards more digitized and patient-friendly healthcare options.
- Enhanced convenience in health services reflects the growing acceptance and integration of technology in medical practices.
Eyebot's successful funding round highlights the growing trend of technology-driven solutions in healthcare, indicating a shift towards more accessible and patient-centered services in eye care. As they scale, their model could pave the way for broader innovation across health sectors.